Is it safe to take 12 mg ivermectin daily?

12 mg Ivermectin Daily is NOT Safe and NOT Recommended

Taking 12 mg ivermectin daily is unsafe and not supported by any guideline or FDA approval. This dosing regimen significantly exceeds approved therapeutic protocols and poses serious safety concerns.

Standard Approved Dosing

The FDA-approved dosing for ivermectin is weight-based at 200 mcg/kg (0.2 mg/kg), not a fixed daily dose 1. For a 70 kg adult, this translates to approximately 14 mg as a single dose, not daily administration.

Approved Treatment Regimens:

• Strongyloidiasis: Single dose of 200 mcg/kg 1
• Scabies: 200 mcg/kg orally, repeated in 2 weeks 2
• Parasitic infections: Single dose or intermittent dosing (200 mcg/kg), with repeat doses separated by at least 7-14 days 3

The key distinction: Approved regimens use single doses or intermittent dosing (e.g., days 1,2,8,9,15 for severe cases), never continuous daily administration 2.

Why Daily Dosing is Dangerous

Pharmacokinetic Concerns:

Ivermectin has an 18-hour half-life and is metabolized slowly in the liver, with excretion occurring over approximately 12 days 1. Daily administration would lead to:

• Drug accumulation: Studies show minimal accumulation even with dosing every 4th day (AUC ratios of 1.24-1.40) 4. Daily dosing would dramatically increase plasma concentrations beyond studied levels.
• Hepatotoxicity risk: The safety of multiple doses in patients with severe liver disease is unknown 2

Safety Data Limitations:

High-dose safety studies evaluated doses up to 120 mg (approximately 2000 mcg/kg) as single doses, not repeated daily administration 4. The study specifically noted these were single-dose regimens or dosing every fourth day—not daily 4.

Documented Risks

Known Adverse Events:

• CNS toxicity: Particularly in patients with Loa loa co-infection, ivermectin can cause fatal encephalopathy 1
• Ocular events: Increased in higher-dose regimens, though typically transient 5
• Drug interactions: Increased INR when co-administered with warfarin 1
• Cardiovascular effects: QT prolongation, heart rate reduction 6

Special Populations at Risk:

• Elderly/debilitated patients: One study showed increased mortality, though not confirmed in subsequent reports 2
• Severe liver disease: Safety unknown with multiple doses 2
• Children <15 kg: Not approved 1

What This Dosing Might Indicate

If someone is considering 12 mg daily, they may be:

1. Misunderstanding COVID-19 misinformation: No evidence supports ivermectin for COVID-19 prevention or treatment 7, 8. A 5-day course showed no benefit and should not be used 9, 7, 8.

2. Self-medicating for cancer: Despite preclinical data, there is no clinical evidence supporting ivermectin for cancer treatment, and self-medication has led to toxicity in oncology patients 10

3. Treating parasitic infection incorrectly: Even for severe crusted scabies (the most aggressive indication), the regimen is 200 mcg/kg on specific days (1,2,8,9,15), not continuous daily dosing 2

The Correct Approach

For any legitimate parasitic indication:

• Use weight-based dosing: 200 mcg/kg 3
• Single dose or intermittent dosing only
• Take with food to increase bioavailability 2
• Minimum 7-14 day interval between doses for standard indications 2

Critical caveat: Before any ivermectin use, patients with exposure to Loa loa-endemic areas (West/Central Africa) require pretreatment assessment to prevent fatal encephalopathy 1.

Bottom line: 12 mg ivermectin daily has no approved indication, exceeds all studied safe regimens, and poses significant risk of drug accumulation and toxicity. This regimen should be immediately discontinued and replaced with evidence-based, guideline-concordant therapy if treatment is truly indicated.